Affordable Access

deepdyve-link
Publisher Website

Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs.

Authors
  • Hex, N
  • Bartlett, C
  • Wright, D
  • Taylor, M
  • Varley, D
Type
Published Article
Journal
Diabetic Medicine
Publisher
Wiley (Blackwell Publishing)
Publication Date
Jul 01, 2012
Volume
29
Issue
7
Pages
855–862
Identifiers
DOI: 10.1111/j.1464-5491.2012.03698.x
PMID: 22537247
Source
Medline
License
Unknown

Abstract

Type 1 and Type 2 diabetes are prominent diseases in the UK and are a significant economic burden. Data differentiating between the costs of Type 1 and Type 2 diabetes are sparse. Complications related to the diseases account for a substantial proportion of the direct health costs. As prevalence increases, the cost of treating complications will grow if current care regimes are maintained.

Report this publication

Statistics

Seen <100 times